123 related articles for article (PubMed ID: 9208647)
1. [Effect of thyrotropin-releasing hormone analogue (YM14673) on experimental brain contusion and edema in rats].
Zhang JJ; Zhang SD
Yao Xue Xue Bao; 1996; 31(4):250-3. PubMed ID: 9208647
[TBL] [Abstract][Full Text] [Related]
2. A novel TRH analog, YM14673, stimulates intracellular signaling systems in the brain more potently than predicted by its pituitary actions.
Mori M; Iriuchijima T; Yamada M; Murakami M; Kobayashi S
Res Commun Chem Pathol Pharmacol; 1991 Jan; 71(1):17-26. PubMed ID: 1673800
[TBL] [Abstract][Full Text] [Related]
3. Effects of YM-14673, a new TRH analogue, on responses to morphine in rodents.
Yamamoto M; Shimizu M; Ozawa Y
Arch Int Pharmacodyn Ther; 1989; 300():29-36. PubMed ID: 2515820
[TBL] [Abstract][Full Text] [Related]
4. A novel analog of TRH, YM14673, causes a decrease in brain TRH receptors in vitro.
Monden T; Mizuma H; Yamada M; Murakami M; Mori M
Endocr Res; 1995 Nov; 21(4):803-14. PubMed ID: 8582330
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
Shimizu M; Yamamoto M; Kobayashi M
Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
[TBL] [Abstract][Full Text] [Related]
6. Effects of YM-14673, a new TRH analogue, on behavioral and electrophysiological changes in rats subjected to electrical lesion of the internal capsule.
Yamamoto M; Shimizu-Sasamata M; Kawabata S; Terai M
Arch Int Pharmacodyn Ther; 1990; 306():5-17. PubMed ID: 2127525
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
Yamamoto M; Shimizu M
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
[TBL] [Abstract][Full Text] [Related]
8. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
[TBL] [Abstract][Full Text] [Related]
9. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective.
Roof RL; Duvdevani R; Heyburn JW; Stein DG
Exp Neurol; 1996 Apr; 138(2):246-51. PubMed ID: 8620923
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
Matsui K; Wada K; Kwak S
Eur J Pharmacol; 1994 Mar; 254(3):295-7. PubMed ID: 8013566
[TBL] [Abstract][Full Text] [Related]
11. Effect of ifenprodil, a polyamine site NMDA receptor antagonist, on brain edema formation following asphyxial cardiac arrest in rats.
Xiao F; Pardue S; Arnold T; Carden D; Alexander JS; Monroe J; Sharp CD; Turnage R; Conrad S
Resuscitation; 2004 May; 61(2):209-19. PubMed ID: 15135198
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia.
Yamamoto M; Shimizu M; Okamiya H
Eur J Pharmacol; 1990 Jun; 181(3):207-14. PubMed ID: 2116971
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new thyrotropin-releasing hormone analogue administered in rats 1 week after middle cerebral artery occlusion.
Yamamoto M; Tamura A; Kirino T; Hirakawa M; Shimizu M; Sano K
Stroke; 1989 Aug; 20(8):1089-91. PubMed ID: 2756541
[TBL] [Abstract][Full Text] [Related]
14. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats.
Yamamoto M; Tamura A; Kirino T; Shimizu-Sasamata M; Sano K
Eur J Pharmacol; 1991 May; 197(2-3):117-23. PubMed ID: 1915564
[TBL] [Abstract][Full Text] [Related]
15. Comparison of single and combination drug treatment strategies in experimental brain trauma.
Faden AI
J Neurotrauma; 1993; 10(2):91-100. PubMed ID: 8411221
[TBL] [Abstract][Full Text] [Related]
16. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
Yamamoto M; Ozawa Y; Takeuchi H
Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
[TBL] [Abstract][Full Text] [Related]
17. [Protective action of thyroliberin and its synthetic analog (PR-546) in craniocerebral trauma].
Gurskaia IE; Pleukhova OA; Beliakov NA; Kuz'michev SA; Servatinskiĭ GL; Romanovskiĭ PIa
Biull Eksp Biol Med; 1990 May; 109(5):432-4. PubMed ID: 2116194
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of glucose-6-phosphate polyclonal antibody on vasogenic brain edema in rats].
Tao Z; Lu BX; Zhang YZ; Cheng G
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1041-3. PubMed ID: 16864109
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance learning in senescence-accelerated mice.
Yamamoto M; Iwai A; Ozawa Y
Pharmacol Biochem Behav; 1990 Mar; 35(3):727-9. PubMed ID: 2111030
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats.
Okada M
J Neurochem; 1991 May; 56(5):1544-7. PubMed ID: 1901593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
